Sarepta stands behind Elevidys after FDA requests gene therapy be pulled from market

21st July 2025 Uncategorised 0

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm behind its approved Duchenne muscular dystrophy treatment. The FDA, for its part, is asking the company to pull the drug from the market.

More: Sarepta stands behind Elevidys after FDA requests gene therapy be pulled from market
Source: fierce